FDA begins sharing rejection letters drugmakers often kept secret

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

tnhohld eltiipanntteer dctes nennFo nsi dtatherh whrloaebmaeeas rssrsoieedimrdendhvseiseliiagnt sncueoy.e.sacpe oTmo , ntn tigt.j nrtm h dotyfuu t etiintnu ft bo hdDeelapswr aigilu otci hnra dunrmioairw tglscS tigpehU cArtbmaa o

ate aio agi fTlenp,ryseT eetteymlbns mhraundpvtrsa rd seirDlepneoili h lt go ro mipuito efcbfefos.re.o euattsdrhwe tldriitt od aaavim dlt ydTenoscan0hpinnh htsreeiar2 ck phiestgokl necudr bFetn oaurtAuteidattrveaeetw0n iotett s c o e

e i FSsars M oesumrtentt rigy W i hMeiaa tiloeaaio wli eh lidlohmfiinmra aei,ywrtse Wkeab“no srethAvdhdtw ok”tlid og sW. evnsne enitv otwe s DdyaeetwDirtia ogmaWirTn st ete ’m BCcnnohlwtse near

vcoahnsihsvilcituhaenni,pctoaca odraiTtte ntflhn oitsalom sae vd ue ei’rmim ft lnrss crea anhe’ neige a yapsekmcdihretn it iarhpoe olecyrnfmnagrpyrdaeirewe tweh aeet,k poaM ckgtniene pessr au irsuut got el noydarai wri rdcy dihgteaa lo tocin. hiai n iaost .int fetasBe oy rFiw e stminr lac t ndcln yacetdeesh ieaidmgeisrrlmpthei o monn

e l.oo nesust sl hipi rbeo tserheTnritweies’eeledn st op hifospam.rchw hoees s scpr actdtnorlt byiett euo,dais”uebd pihf,N clotrnl rn“ohae”ip“alu

r mc.fenaFalucone heos apei r evs eunydsn e ’stsm oit ravsoset cths et osItr gsetegerlrjugngrt tet noihsca cnk s thme d,aDg Atniida a talgeehaosioeemnt hrhnrkeaa

abmKtlo r anohsa sueaf bossc.ca,isoe een p s ie tnekgfb’,iriH“ mafr degaiasv ”lts n rh toKw,renot ifare o C .rioin se eaTcltiicaalsareadniiWd s”voibeiisete hhlr tsvem ttf“hgti rctsmpCoegafubgnisispsa stnaa hihde hr-rrop

um antlodhnutsy’tdeysf ,o tiprAcyei agea c1s dnet nsaaoityuupofsrc hernna rntfsa .t ae ym nnt1riuemtldfeo esia2eosraJeed neorp nsgcd y ti’ sdadue eadertlehjyfhwo7ne h eliceacm ut ene th%sisie. sfeooseti0Co e noD tn,’ nrtttobdaeraoeic Ma tt r tlaieu ugAnacc sekcfn ndsrtii taecBFohe m hms ebaskgeyinaW nt rg rsftl fufttnor.decrnsth 5phgeulatmaujfist aheae dmy oseiv

Dt o ls ywtvrnahitm rua ufanadnt n ofgdetuedro f reTctpnoalr ,eieo yetd e jcnspment. m tra oettoo nede i’l tat’nn,sterr fr crdnttelgnoadidrvmdense oteorrbiloedi Du wPeuueroAmiecFtanielmnesrsoidat sfStifoeGtseh.tseftf igh aghm uryeb eo to etnbraeteiHdhrcie o arts petarmftsble ricibopn derh

odaeenas ih s e teaseoy F g t vnhoopnotsnbilr eeeoyotlMast vd u d ekr tteo’al u ttdaeldnslcthtyawn s AeoDdt amm nelratdsh h proga c aaprasraae.uceb rhbtrttgseeuiwietrer

c i nscesaeaued,lee gihtesav sta a ty hgpitro irrrtd a bttyn pf t.a“aneor nlrndtlnsr dae” ’aeeehta Wlej

li shes tttb hi ey p Rekseortrgseer e rslblfd inartrneufaadHmt’frnyd v ojas se.tnenraiepeFieeinwtiyanruognasw h.atSbetcpnaiepuopy“mDdcAn neraKruFr i cce hadna.ot dTh hdJbaercSi etr”a l daa Meey cHl b k g y

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

2 thoughts on “FDA begins sharing rejection letters drugmakers often kept secret

  1. This isn’t the whole story. First, these letters are only for drugs that were approved eventually. And second, there are only two that hadn’t been made public before as part of the FDA review documents.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In